Skip to main content
Log in

β-Lactam antibiotics in the treatment of neuroborreliosis in children: Preliminary results

β-Lactam Antibiotika zur Behandlung der Neuroborreliose im Kindesalter: Vorläufige Ergebnisse

  • Special Addendum — Part II
  • Therapy And Prophylaxis In Lyme Borreliosis
  • Published:
Infection Aims and scope Submit manuscript

Summary

In vitro β-lactam antibiotics like ceftriaxone and penicillin G sodium have been shown to be active againstBorrelia burgdorferi. Results of quantitative determinations of both antibiotic substances in the CSF for children are limited. Seventy-five children (median age 96 months, range 10 to 176 months) with probable or definite neuroborreliosis were treated with ceftriaxone (1×50–90 mg/kg/day) or penicillin G sodium (4×80,000–120,000 IU/kg/day) intravenously. On day 10 of therapy levels of penicillin G sodium (1, 1.5, 2, 3, 4, 5, or 6 h after i.v. administration), and ceftriaxone (1, 2, 4, 6, 12 or 24 h after i.v. administration) in serum and CSF were measured with a micro agar diffusion bioassay. Results demonstrate that after 5 h penicillin G sodium in CSF was above the minimal inhibitory concentration (MIC) but after 6 h penicillin G sodium levels were below the determination limit in 60% of the cases. All ceftriaxone results in CSF — even after 24 h — were above MIC. Penicillin G sodium serum values ranged from 46.6 to 0.1 mg/l (1 to 6 h post dose) and ceftriaxone serum values from 261 to 5 mg/l (1 to 24 h post dose). The role of penicillin G sodium and ceftriaxone and administration intervals of both antibiotics in the therapy of neuroborreliosis in children are discussed.

Zusammenfassung

Ceftriaxon und Natrium-Penicillin G sind gegenBorrelia burgdorferi in vitro wirksam. Zur Pharmakokinetik beider Substanzen im Liquor cerebrospinalis von Kindern ist hingegen wenig bekannt. 75 Kinder im Alter von 10 bis 176 Monaten (Median 96) mit einer definitiven oder möglichen Neuroborreliose wurden intravenös mit Ceftriaxon (1×50–90 mg/kg/Tag) oder Penicillin G (4×80000–120000 I.E./kg/Tag) behandelt. Am 10. Therapietag wurden die Liquor-Spiegel von Penicillin G (1, 1.5, 2, 3, 4, 5, oder 6 Stunden nach Gabe) bzw. Ceftriaxon (1, 2, 4, 6, 12, oder 24 Stunden nach Gabe) in Serum und Liquor aus gepaarten Proben mittels einer Mikroagar Diffusions-Methode gemessen. Die Ergebnisse zeigen, daß Penicillin G 5 Stunden nach Gabe noch über der minimalen Hemmkonzentration lag, daß aber 6 Stunden nach Gabe die Konzentration des Antibiotikums in 60% der Liquorproben bereits unterhalb der Meßgrenze lag. Die Ceftriaxon Liquorspiegel lagen durchwegs über der MHK — auch noch 24 Stunden nach der letzten Gabe. Die Serumkonzentrationen von Penicillin G lagen zwischen 46,6 und 0.1 mg/l, die Serumkonzentrationen von Ceftriaxon zwischen 261 und 5 mg/l. Die vorgestellten Ergebnisse werden im Hinblick auf den Stellenwert der beiden Antibiotika in der Therapie der Neuroborreliose im Kindesalter diskutiert.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Preac Mursic, V., Wilske, B., Schierz, G. EuropeanBorrelia burgdorferi isolated from human and ticks: culture conditions and antibiotic susceptibility. Zbl. Bact. Hyg. A 263 (1986) 112–118.

    Google Scholar 

  2. Johnson, S. E., Klein, G. C., Schmid, G. P., Feeley, J. C. Susceptibility of the Lyme disease spirochete to seven antimicrobial agents. Yale J. Biol. Med. 57 (1984) 549–553.

    Google Scholar 

  3. Berger, B. W., Kaplan, M. H., Rothenberg, I. R., Barbour, A. G. Isolation and characterization of the Lyme disease spirochete from the skin of patients with Erythema chronicum migrans. J. Am. Acad. Dermatol. 13 (1985) 444–449.

    Google Scholar 

  4. Mursic, V. P., Wilske, B., Schierz, G., Holmburger, M., Süss, E. In vitro andin vivo susceptibility ofBorrelia burgdorferi. Eur. J. Clin. Microbiol. 6 (1987) 424–426.

    Google Scholar 

  5. Luft, B. J., Halperin, J. J., Volkman, D. J., Dattwyler, R. J. New chemotherapeutic approaches in the treatment of Lyme disease. Ann. N. Y. Acad. Sci. 539 (1988) 93–102.

    Google Scholar 

  6. Grubbauer, H. M., Dornbusch, H. J., Dittrich, P., Weippl, G., Mutz, G. I., Zobel, G., Georgopoulos, A., Fotter, R. Ceftriaxone monotherapy for bacterial meningitis in children. Chemotherapy 36 (1990) 441–447.

    Google Scholar 

  7. Martin, E., Koup, J. R., Paravicini, U., Stöckel, K. Pharmacokinetics of ceftriaxone in neonates and infants with meningitis. J. Pediatr. 105 (1984) 475–481.

    Google Scholar 

  8. Reiber, H. The discrimination between different blood-CSF barrier dysfunctions and inflammatory reactions of the central nervous system by a recent evaluation graph for the protein profile of cerebrospinal fluid. J. Neurol. 224 (1980) 89–99.

    Google Scholar 

  9. Georgopoulos, A. A simple micro agar diffusion method for the determination of antibiotic concentrations in blood and other body fluids. Zbl. Bakt. Hyg. 242 (1978) 287–293.

    Google Scholar 

  10. Johnson, R. C., Kodner, C., Russell, M. In vitro andin vivo susceptibility of the Lyme disease spirochete,Borrelia burgdorferi, to four antimicrobial agents. Antimicrob. Agents Chemother. 31 (1987) 164–167.

    Google Scholar 

  11. Granich, G. G., Krogstad, D. J. Ion pair high performance liquid chromatographic assay for ceftriaxone. Antimicrob. Agents Chemother. 31 (1987) 385–388.

    Google Scholar 

  12. Millner, M. M., Müllegger, R. R., Dittrich, P., Kukovetz, W. R., Stanek, G. Ceftriaxone CSF levels in children with aseptic meningitis: Is a single dose per day enough? Ped. Neurol. 8 (1992) 350.

    Google Scholar 

  13. Spector, R. Ceftriaxone transport through the blood-brain barrier. J. Infect. Dis. 156 (1987) 209–211.

    Google Scholar 

  14. Suzuki, H., Sawada, Y., Sugiyama, Y. Facilitated transport of benzylpenicillin through the blood-brain barrier in rats. J. Pharmacobiodyn. 12 (1989) 182–185.

    Google Scholar 

  15. Spector, R., Johanson, C. E. The mammalian chorioid plexus: structure, development and function. Sci. Am. 261 (1989) 68–74.

    Google Scholar 

  16. Spector, R. Ceftriaxone pharmacokinetics in the central nervous system. J. Pharmacol. Exp. Ther. 236 (1986) 380–383.

    Google Scholar 

  17. Suzuki, H., Sawada, Y., Sugiyama, Y. Transport of benzylpenicillin by the rat chorioid plexusin vitro. J. Pharmacol. Exp. Ther. 242 (1987) 660–665.

    Google Scholar 

  18. Nohjoh, T., Suzuki, H., Sawada, Y. Transport of cefodizime, a novel third-generation cephalosporin antibiotic, in isolated rat chorioid plexus. J. Pharmacol. Exp. Ther. 250 (1989) 324–328.

    Google Scholar 

  19. Schaad, U. B., Hayton, W. L., Stöckel, K. Single-dose ceftriaxone kinetics in the newborn. Clin. Pharmacol. Ther. 37 (1985) 522–528.

    Google Scholar 

  20. Millner, M. M., Müllegger, R. R., Spork, K. D., Stanek, G. Lyme borreliosis of central nervous system (CNS) in children: a diagnostic challenge. Infection 19 (1991) 273–278.

    Google Scholar 

  21. Mursic, V. P., Wilske, B., Schierz, G., Holburger, M., Süss, E. In vitro andin vivo susceptibility ofBorrelia burgdorferi. Eur. J. Clin. Microbiol. 6 (1987) 424–426.

    Google Scholar 

  22. Schaller, M., Neubert, U. Ultrastructure ofBorrelia burgdorferi after exposure to benzylpenicillin. Infection 22 (1994) 401–406.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Millner, M.M., Thalhammer, G.H., Spork, K.D. et al. β-Lactam antibiotics in the treatment of neuroborreliosis in children: Preliminary results. Infection 24, 174–177 (1996). https://doi.org/10.1007/BF01713334

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01713334

Keywords

Navigation